| Name | Title | Contact Details |
|---|
We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.
Nevada Health Centers, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Nevada Health Centers, Inc. is based in Carson City, NV. You can find more information on Nevada Health Centers, Inc. at www.nvrhc.org
Smart devices and digital support that connect patients to care, with clinically-proven results https://t.co/zoMxznOfwA
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.
Care Access Health Plan is a Hallandale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.